Axsome Therapeutics Acquires Global Rights to Balipodect from Takeda

Sidley has advised Axsome Therapeutics. White & Case has advised Takeda Pharmaceutical Company Limited. Axsome Therapeutics, Inc. (Nasdaq: AXSM) has acquired exclusive global rights to TAK-063…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here